Advertisement

Mobile Banner
Mobile Banner
Mobile Banner
Loading...

Novartis AG

NVSNYSE
Healthcare
Drug Manufacturers - General
$164.68
$0.76(0.46%)
U.S. Market is Open • 14:21

Novartis AG (NVS) Stock Overview

Explore Novartis AG’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap314.5B
P/E Ratio22.36
EPS (TTM)$7.14
ROE0.33%
Fundamental Analysis

AI Price Forecasts

1 Month$161.58
3 Months$166.09
1 Year Target$152.14

NVS Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Novartis AG (NVS) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 71.27, suggesting the stock is in an overbought condition. Our forecasting models predict significant price movements, with a 12-month target of $152.14.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 22.36 and a market capitalization of 314.5B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
-0.76%
5-Day Change
0.32%
1-Month Change
13.30%
3-Month Change
30.81%
6-Month Change
27.84%
Year-to-Date (YTD) Change
17.42%
1-Year Change
51.60%
3-Year Change
98.15%
5-Year Change
95.55%
All-Time (Max) Change
934.20%

Contact Information

41 61 324 1111
Lichtstrasse 35, Basel, NaN, 4056

Company Facts

758,830 Employees
IPO DateNov 7, 1996
CountryCH
Actively Trading

Frequently Asked Questions